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Abstract
In causal inference, interest often lies in estimating the joint effect of treatment on
outcome at different time points. Marginal structural models are particularly useful for this
purpose when a time-dependent confounder exists in the causal path between the treatment
assigned in the previous time and the outcome. These models provide a consistent estimate
when treatment is measured perfectly. In practice however, treatment may be subject to
measurement error. Many studies have shown that measurement error in treatment can result
in underestimating its effect. One approach proposed in the literature for correcting this
problem is the marginal structural measurement-error model. It requires using a validation
data set in which both the true treatment and the observed treatment are available to correct
the bias. In this study, we developed a new method which combines the marginal structural
Cox proportional hazards model, the regression calibration method, and the Bayesian method
to account for measurement error in treatment without the need for a validation data set.
Moreover, instead of fitting a traditional pooled logistic regression model, a weighted Cox
proportional hazards model is implemented to reduce bias. The performance of our proposed
method was assessed through the simulation study. Our simulation results show that the bias
is reduced even with an approximate value of the parameter of the prior distribution. Our
sensitivity analysis also shows that the estimated treatment effect is robust to the choice of
the prior distribution. We applied our proposed method to estimate the effect of highly active
antiretroviral therapy on the incidence of acquired immune deficiency syndrome or death
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among HIV-positive patients using a data set in which the observed treatment assignment
was subject to misclassification. Public Health Significance: Measurement errors can
happen in medical studies despite good intentions. In general, either a validation data set
or the replicates of the observed predictor are needed to correct for bias in estimation. Our
study provides a new method in causal inference for correcting bias caused by measurement
errors when investigators only have the main data set in which the observed treatment is
measured only once at each time point.
KEY WORDS : Bayesian, marginal structural Cox model; misclassification; time-dependent
confounder, treatment causal effect.
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1.0 INTRODUCTION
In the current research in medicine, researchers often collect data from a longitudinal study
in which both treatment assignments and covariate values vary over time. In such events,
a confounder that predicts the subsequent treatment assignment and the outcome could
be time-dependent. Moreover, this time-dependent confounder could be predicted by the
treatment assignment at the previous time point. Robins (1997) showed that in this complex
longitudinal data, the standard methods, such as regression, stratification, and matching,
might result in a biased estimate of the joint effect of treatment on the outcome at various
time points regardless this time-dependent confounder is adjusted or not. Robins (1998) later
developed marginal structural models in order to estimate the causal effect of treatment on
the outcome consistently.
It is well known that incorrectly recorded treatment assignments may result in a biased
estimated treatment effect and the solutions for correcting the bias can be found in a large
body of literature. However, less attention has been given to estimating the causal effect of
treatment when treatment is measured imperfectly in the above mentioned complex longitu-
dinal data. Cole et al. (2010) proposed a marginal structural measurement-error model (will
be described in detail in Section 1.3) and applied their method to obtain a bias-corrected
estimator of treatment effect on the survival. In order to apply their method, a validation
data set is needed in which both true treatment and misclassified treatment are recorded.
In most of the situations, a validation data set does not exist. The objective of our study
is to develop a marginal structural Cox model to estimate the causal effect of treatment on a
survival outcome when the treatment assignment might be misclassified and the validation
data set is not available. In Section 1.1, we will review causal effects and the marginal
structural models proposed by Robins (1998). In Section 1.2, we will review methods for
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adjusting measurement errors. In Section 1.3, we will provide a detailed description of the
marginal structural measurement-error model proposed by Cole et al. (2010) which is the
basis of our proposed model.
1.1 CAUSAL EFFECT AND MARGINAL STRUCTURAL MODELS
Let Ya=1 and Ya=0 be the outcome that would have been observed had a subject been
treated (a = 1) and untreated (a = 0), respectively. Ya=1 and Ya=0 are referred to as the
counterfactual outcomes. Since in reality everyone can only be either treated or untreated,
every subject at most can contribute to only one counterfactual outcome.
According to the definition of Robins and Herna´n (2008), causation can be demonstrat-
ed by comparing the marginal expected value of the counterfactual outcome E(Ya=1), in
which every subject in the population were treated, with that of the counterfactual out-
come E(Ya=0), in which every subject in the same population were untreated. If E(Ya=1) 6=
E(Ya=1), the treatment A has an average causal effect on the outcome Y in that population.
Since for every subject only one of the counterfactual outcomes is observed, the causal effect
cannot be estimated directly. In contrast, association can be demonstrated by comparing
the conditional expected value of the observed outcome in the treated group E(Y |A = 1)
with that in the untreated group E(Y |A = 0). The associational effect can be estimated
directly. Figure 1 shows the difference between causation and association.
In order to consistently estimate the average causal effect of the treatment A on the out-
come Y in a population, one needs to link the causation to the association. The identifiability
conditions are necessary but not sufficient for this linkage.
1. Consistency: if A¯ = a¯ , then Ya¯ = Y for that subject, where A¯ is the treatment history,
a¯ is its possible value. Consistency means that Ya¯, a subject’s counterfactual outcome
under treatment history a¯, equals to his observed outcome Y if his observed treatment
history A¯ happens to be a¯.
2. Conditional exchangeability: Ya¯ ⊥ A(t)|A¯(t− 1) = a¯(t− 1), L¯(t) = l¯(t) for all a¯ and l¯(t),
where L¯(t) is the covariate history up to time t and l¯(t) is its possible value. Conditional
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exchangeability means that the counterfactual outcome is independent of the treatment
given the treatment and covariate histories. The assumption also implies there is no
unmeasured confounder. Under this condition, the equations E{Ya(t)=1|A(t) = 1} =
E{Ya(t)=1|A(t) = 0} = E{Ya(t)=1} and E{Ya(t)=0|A(t) = 1} = E{Ya(t)=0|A(t) = 0} =
E{Ya(t)=0} will hold.
3. Positivity: if P{a¯(t − 1), l¯(t)} 6= 0, then P{a(t)|a¯(t − 1), l¯(t)} > 0 for all a(t), where P
denotes the probability. It means that among the subjects who have the same treatment
and covariate histories in the underlying population, the probability of the assignment
of any available treatment should be larger than 0. For example, if in the underlying
population all patients who have the same treatment and covariate histories are treated,
then the probability of not receiving treatment is 0, thus positivity is violated.
Positivity ensures that for a given subject, his counterparts, who have the same treatment
history A¯(t−1) and covariate history L¯(t) but different current treatment A(t), are available
in the underlying population. Conditional exchangeability ensures that this subject and his
counterparts would have the same expected value of the counterfactual outcome had they
received the same treatment, so the information of the missing counterfactual outcome for a
subject can be retrieved from the counterparts. Consistency ensures that the counterfactual
outcomes can be identified from the observed outcomes. In short, conditional exchangeability
ensures that every subject is exchangeable with his counterparts, and positivity ensures the
availability of his counterparts, and consistency ensures that the counterfactual outcomes
are observable.
The identifiability conditions hold in a marginal or conditional randomized experiment.
If the conditions hold in an observational study, this observational study is equivalent to a
conditional randomized experiment, therefore, it is possible to estimate the causal effect of
treatment on outcome. However, Robins and Herna´n (2008) demonstrated that one might
obtain a biased estimated causal effect of treatment on outcome using the conventional
methods, such as regression, stratification, and matching, when time-dependent confounder
exists in the causal path between the treatment assigned at the previous time point and
the outcome. According to the definition of Robins and Herna´n (2008), if the identifiabil-
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ity conditions hold, yet E(Ya¯|L0) 6= E(Y |A¯ = a¯, L0), where L0 is the vector of baseline
covariates, a time-dependent confounder exists. Figure 2 illuminates this situation. L1 pre-
dicts the subsequent treatment A1 and the outcome Y given the baseline variables. Thus,
E(Ya¯|L0) 6= E(Y |A¯ = a¯, L0) and L is the time-dependent confounder. Treatment A0 also
predicts the time-dependent confounder L1. If one wants to consistently estimate the causal
effect of A1 on the outcome Y , he should adjust the confounder L1. However, L1 is the
collider of the treatment A0 and the unmeasured factor U . By conditioning on L1, subjects
with a certain association between U and A0 are more likely to present in a certain level of
L1, thus a “selection bias” Robins and Herna´n (2008) is introduced. Also, L1 is in the causal
path of A0 and Y . By adjusting for L1 one can remove the treatment effect of A0 on the
outcome Y . Therefore, conventional methods cannot provide a consistent estimator of the
joint effect of A0 and A1 on the outcome Y.
To address the above mentioned issue, Robins (1998) developed a new method, the
marginal structural models, for estimating the causal effect of treatment consistently in
this complex longitudinal data. He proved that the estimated parameter from the marginal
structural models is a regular asymptotically linear estimator of the true parameter, and thus
it is an asymptotically unbiased estimator. In order to perform a marginal structural model,
a pseudo-population is created using the inverse probability treatment weighting (IPTW)
method by which subject i at time j is assigned a weight Wij which equals to the inverse
conditional probability of receiving his current actual treatment given the treatment and
covariate histories. Thus, in pseudo-population, every subject not only represents himself
but also the Wij − 1 subjects, who have the same treatment and covariate histories but
different current treatment. That is, in the pseudo-population the treated sub-population
includes the exactly the same patients as the untreated sub-population does. This exactly
meets the definition of causation given by Robins and Herna´n (2008). Robins and Herna´n
(2008) stated that E(Ya) in the pseudo-population equals to that in the actual population,
and that the time-dependent confounder L which exists in the actual population is no longer
a confounder in the pseudo-population. After creating the pseudo-population, one can fit
a model, such as, linear model, logistic model, or Cox proportional hazards model in the
pseudo-population. Figure 3 illustrates the underlying idea of marginal structural models.
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In our study, what we are interested in is the hazard of the event, not the expected value of
the outcome.
1.2 MEASUREMENT ERROR IN PREDICTOR
The problem caused by measurement error in predictor is not rare in medical study since
variables can be measured imperfectly for a variety of reasons. Usually, the word “mea-
surement error” is used to describe the continuous variables which are measured with error,
whereas “misclassification” is used to describe the categorical variables. In order to correct
for the bias in the estimator caused by measurement error, one needs an outcome model
which relates the outcome with the true predictor and a measurement error model which
relates the true predictor with the observed predictor. Carroll et al. (2006) described two
commonly used measurement error models, the Classical measurement error model and the
Berkson measurement error model, as well as other measurement error models that are less
frequently used. Let X denote the observed predictor, Z denote its underlying true value,
and U denote the measurement error. The classical measurement error model assumes that
X = Z + UC , UC ∼ N(0, σ2C), whereas the Berkson measurement error model assumes that
Z = X + UB, UB ∼ N(0, σ2B). Although the difference in the forms is subtle, they are very
different models. If the error prone predictor is measured from each individual, the classical
measurement error model is suitable. If all subjects in a small group are assigned with the
same value for the predictor, then the Berkson measurement error is preferable.
The effect of measurement error in the predictor depends on the outcome model as well as
the measurement error model. Carroll et al. (2006) showed that in simple linear regression,
the classical type of measurement error results in an attenuated estimated coefficient of the
mismeasured predictor, whereas the Berkson type of measurement error does not. Carroll
(2011) proved that in multiple linear regression, the classical type of measurement error biases
estimators for the mismeasured predictor as well as those covariates measured perfectly,
unless they are independent. Carroll (2011) also showed that if there is more than one
covariate measured with error, the estimated coefficients could be biased toward or away
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from 0. Reeves et al. (1998) proved in logistic regression model, both the classical type
and the Berkson type of measurement errors bias the estimated coefficient of the associated
variable toward 0. Li and Ryan (2004) proved that in Cox proportional hazards model the
measurement error attenuated the estimated coefficients for both the mismeasured predictor
and the variable measured correctly, even though they were independent.
Carroll et al. (2006) also illustrated that the variance of the estimated coefficient of the
mismeasured predictor is larger than that of the estimated true predictor effect, thus the
measurement error in the predictor causes the loss of statistical power.
The problem of measurement errors has received a great deal of attention and different
techniques have been developed to allow for the measurement error in predictor. Regression
calibration method Carroll et al. (1995) is one of the commonly used methods. Instead of
using the true predictor Z, this method use E(Z|X) as predictor and then fit a standard
model. If the validation data set in which both X and Z are recorded is available, one can fit
model to regress Z on X in the validation data set and calculate the estimator of E(Z|X) in
the main data set, and then fit a standard model using E(Z|X) as the predictor to obtain the
bias-corrected estimated predictor effect. If only the replicates of the observed predictor are
available, one can still estimate E(Z|X). Carroll et al. (2006) and Bartlett (2011) described
how to estimate E(Z|X) in detail. Regression calibration method is potentially applicable
for any model, given one can estimate E(Z|X) correctly. It can reduce the bias in the
estimate in logistic regression model and Cox proportional hazards model, but might still
give a biased estimate when the measurement error is large.
Rosner et al. (1989) developed another version of regression calibration method in logistic
regression. Bias is corrected using the formula θˆ = βˆ/γˆ1 under the assumptions that the
disease is rare, the measurement error is not large and non-differential, meaning that the
outcome is independent of the observed predictor given the true predictor, where θˆ and
βˆ was the estimated effect of the true predictor, and the estimated effect of the observed
predictor on the outcome, respectively, and γˆ1 was the estimated coefficient in the linear
model Z = γ0 + γ1X + ,  ∼ N(0, σ2). The measurement error could be either a random
error or systematic error. That is, the mean of the measurement error does not have to be 0.
They extended their method to the case where there was more than one predictor measured
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with error Rosner et al. (1990), and to the case where only the replicates of the mismeasured
predictor were available Rosner et al. (1992).
Prentice (1982) first discussed the measurement errors problem in Cox proportional haz-
ards model. Assuming the measurement error is non-differential, he derived the induced
hazard function λ{t;X(t)} = λ0E{T≥t,X(t)} exp{Z(t)θ}, where λ0 is the baseline hazard,
and θ is the parameter of interest. However, the relative risk E{T≥t,X(t)} exp{Z(t)θ} in
the induced hazard function depends on the baseline hazard, but this dependency can
be ignored when the risk of event is low. He then gave the partial likelihood L(θ) =∏k
i=1[
∏
l∈F (ti) E exp{zl(ti)θ}]/[
∑
l∈R(ti) E exp{zl(ti)θ}]mi under the assumption that the cen-
soring is non-informative. By specifying the conditional distribution of f(Z|X) in each risk
set, one then can obtain the bias-corrected coefficient of the true predictor. Spiegelman
et al. (1997) indicated that the bias-corrected estimate derived from Prentice’s method also
has the form θˆ = βˆ/γˆ1 under the assumptions that the linear measurement error model in
Rosner’s method is valid, the measurement error is small and non-differential, the censoring
is non-informative, and the event risk is low. Thus, the relationship θˆ = βˆ/γˆ1 holds in both
logistic regression and Cox proportional hazards model.
Another approach for correcting the bias in estimate caused by measurement error in
predictor is Bayesian method. Tadesse et al. (2005) developed Bayesian error-in-variable
model which solves the problem of measurement error in predictor through the Bayesian
approach. In general, in order to perform the Bayesian analysis, one needs to specify the
outcome model f(Y |Z, θ) which could be the Cox model, and the measurement error model
such as the Berkson measurement error model f(Z|X). The likelihood is the product of
these two models. By specifying the prior distribution of the parameter θ, one can have the
joint posterior distribution of θ and Z and the conditional posterior distribution for θ and Z,
respectively, and estimate the bias-corrected coefficient from the corresponding conditional
posterior distribution. The true predictor Z is estimated by drawing it from its conditional
posterior distribution according to other known information. Tadesse et al. (2005) assumed
the baseline hazard was a constant within each disjoint small interval and used the full
likelihood of Cox model to perform the analysis. Sinha et al. (2003) proposed the use of the
Breslow (1974) type of partial likelihood to obtain the posterior distribution if the outcome
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model is the Cox proportional hazard model, thus simplified the computational process of
implementing Cox model through the Bayesian approach.
Nakamura (1992) applied the corrected score function method developed by Nakamu-
ra (1990) to the Cox proportional hazards model and obtained asymptotically unbiased
estimate under the assumption that the measurement errors are additive and normally dis-
tributed. He corrected the bias by adding a term to the naive score function Λθ, where
Λ is the known measurement error variance and θ is the unknown parameter of inter-
est; therefore, the corrected score function was defined as U∗i (θ,X, Y ) = Ui(θ,X, Y ) + Λθ
and U∗(θ,X, Y ) =
∑
U∗i (θ,X, Y ), where Ui(θ,X, Y ) is the naive score function for sub-
ject i derived from the partial likelihood with X as the predictor. Nakamura showed that
E{U∗(θ,X, Y )} ≈ U(θ, Z, Y ) if θTΛθ is small. The estimator from the corrected score func-
tion is an approximately unbiased estimator.
Tsiatis and Davidian (2001) developed the conditional score method in survival analysis
accounting for the time-dependent covariate that was mistimed and mismeasured. They used
the classical measurement error model and assumed that the true predictor follows random
coefficient linear model; therefore, Xi(tij) = Zi(tij)+eij and Zi(u) = α0i+α1iu, where Xi(tij)
is the observed predictor for subject i at time j, and Zi(tij) is its underlying true value, and
eij is the normally distributed measurement error with mean 0. Their outcome model is
λi(u) = λ0(u) exp{θZi(u) + ηTWi}, where θ and η are the parameters of interest and W is
a covariate vector measured precisely. Conventionally, αi = (α0i, α1i) were assumed to be
normally distributed. The essence of the conditional score method is to relax this assump-
tion by finding the complete sufficient statistic of the random effect αi and “condition away”
the dependence of the hazard function on αi according to its complete sufficient statistic.
They then provided the estimating equations for solving θ and η based on this conditional
intensity process, given the complete sufficient statistic and W . Unlike Nakamura who as-
sumed a known measurement error variance, Tsiatis et al provided a method to estimate the
variance of the measurement error from the data. However, Tsiatis method is asymptotically
equivalent to Nakamura’s method, if Z is time-independent and the variance of measurement
error is known.
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Hu et al. (1998) have developed a likelihood-based approach to account for measure-
ment errors in the predictor in the Cox proportional hazards model. Let X be the ob-
served predictor, Z be the underlying true value, and Y be the outcome. The likeli-
hood is L(Y,X) =
∏n
i=1[
∫
fC(yi|xi, zi) × fM(xi, zi)dz], where fC is the full likelihood of
Cox model and fM is the joint distribution of X and Z. Under the non-differential as-
sumption, fC(yi|xi, zi) = fC(yi|zi). They use the classical type measurement error model
Xi = Zi + Ui, Ui ∼ N(0, σ2u), so fM(x, z) = f(x|z) × f(z). f(x|z) is assumed known. They
provided three inferential methods, fully parametric method in which f(z) was assumed to
be a parametric distribution with the unknown parameters which have to be estimated, and
a nonparametric method in which f(z) was approached using the nonparametric maximum
likelihood estimation of a mixing distribution method, and a semiparametric method in which
f(z) was assumed to be a smooth function and approximated by the Hermite series. De-
tails of the nonparametric maximum likelihood estimation of a mixing distribution method
and the Hermite series are beyond the scope of our study and therefore are not presented.
Parameters were estimated by maximizing the likelihood. The fully parametric method was
not robust to the misspecification of f(z), and the nonparametric method introduced many
additional parameters which have to be estimated. Their simulation results showed that the
semiparametric method was superior to the fully parametric method and the nonparametric
method in multiple scenarios.
1.3 AVAILABLE METHOD AND THE MOTIVATION OF OUR STUDY
All the approaches to correcting measurement errors described in Section 1.2 are regression-
adjustment methods. Robins (1998) has shown that regression-adjustment methods fail to
give consistent estimators of the joint causal effect of treatment at different time points
when there is a time-dependent confounder, which is predicted by the previous treatment
assignments. Cole et al. (2010) developed a marginal structural measurement-error model
to estimate the causal effect of antiretroviral therapy on incidence of acquired immunod-
eficiency syndrome (AIDS) or death among patients with human immunodeficiency virus
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(HIV) infection. The treatment information in their study was collected from self-reported
questionnaires and not all patients provided the correct information about the treatments
they actually received. Their validation data showed that only 84% of patients who received
treatments reported that they did, and 80% of patients who did not receive treatments re-
ported that they did not. Cole et al. (2010) combined the marginal structural Cox model
proposed by Robins (1998) with the regression calibration method proposed by Rosner et al.
(1989) in estimating causal effect of treatment to reduce the bias caused by treatment mis-
classification. The method of Cole et al. (2010) took a three-step approach in estimating the
effect of treatment. In the first step, they fitted a marginal structural Cox proportional haz-
ards model using the self-reported treatment assignments as the predictor in order to obtain
the estimated self-reported treatment causal effect βˆ. In this step, they fitted a weighted
pooled logistic regression model instead of a weighted time-dependent Cox model because
that most of the software packages did not allow for time-dependent weights in fitting a
Cox model. In the second step, they adopted the idea of Rosner et al. (1989) and fitted a
weighted pooled linear regression model E(Zi|Xi) = γ0 + γ1Xi using a validation data set
to estimate γ1, where Xi was the self-reported treatment for patient i, and Zi was the true
treatment which was taken from the patient medical record. In the third step, Cole et al
obtained a bias-corrected treatment effect using the formula θˆ = βˆ/γˆ1. Rosner et al. (1989)
showed that βˆ is an “approximate maximum likelihood estimate” of θγ1 and thus one can
expect βˆ/γˆ1 to be a consistent estimate of θ.
If a validation data set is not available, the method proposed by Cole et al. (2010) cannot
be applied directly. Without validation data, one cannot combine either the regression
calibration method or the likelihood-based method with the marginal structural Cox model
to correct the bias in the estimated treatment causal effect because a validation data set is
required in estimating the relation between the true treatment and the observed treatment.
Although the corrected score function method and the conditional score method for
measurement error adjustments described in Section 1.2 are easy to implement, we cannot
combine either of them with the marginal structural Cox model to obtain a bias-corrected
estimator of treatment causal effect because these two measurement error correction methods
assume that measurement error is normally distributed with mean 0 and a known variance
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or the variance can be estimated from the data. These requirements are not suitable for
our study. For example, the mean of measurement error in our study, which is P1 − P2 may
not be 0, where P1 is the probability of a subject reporting that he was treated but actually
was not treated, and P2 is the probability of a subject reported that he was not treated but
actually was treated.
In the following paragraphs, we will first review the standard marginal structural Cox
model in estimating casual effect of treatment when data without treatment misclassifica-
tion are available and then review the Bayesian measurement-error correction method in
estimating treatment associational effect. Finally, we will describe the difficulties one may
encounter in estimating causal effect of treatment when he/she tries to use the combination
of the Bayesian method and the marginal structural Cox model.
To estimate causal effect of treatment when data without treatment misclassification are
available, a marginal structural Cox model can be used. Using this model, we will first create
a pseudo population that removes the effect of time-dependent confounders on treatment by
assigning a subject with a weight. The weight is equal to the inverse conditional probability
of receiving the current treatment given the previous treatment and covariate histories. A
time-dependent Cox model will then be fitted to this pseudo-population. This is equivalent
to fitting a weighted time-dependent Cox model to the actual population. When treatment
is not misclassified, weights will be calculated from the true treatment. Robins (1998) proved
that treatment effect estimated from the marginal structural Cox model is unbiased.
If we are interested in estimating treatment associational effect θ (not treatment causal
effect), while treatment is possibly misclassified, we can apply the Bayesian measurement-
error correction method to the actual population to reduce bias. To do so, we will first create
a Cox partial likelihood of survival outcome given θ and true treatment Z. Then, we will
create a measurement-error model of true treatment Z given observed treatment X. When a
prior distribution of θ is specified, we will be able to obtain the posterior distribution of θ by
combining the partial likelihood, the measurement-error model, and the prior distribution.
Intuitively, we can construct a weighted partial likelihood of survival outcome given θ and
true treatment Z if we are interested in estimating treatment causal effect when treatment
is possibly misclassified. If we are to do so, we could apply the Bayesian method described
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in the previous paragraph to obtain a bias-corrected estimator. However, the weights should
be calculated from the true treatment Z which is not possible when a validation data is
unavailable. Therefore, combining Bayesian measurement-error method and the marginal
structural Cox model to estimate treatment causal effect is not feasible.
To overcome the above-mentioned problems, we propose to replace the second step of
the method of Cole et al by the Bayesian method when estimating γ1. Once the estimated
γ1 is obtained, we will use the formula θˆ = βˆ/γˆ1 to obtain a bias-corrected treatment effect,
which is the last step of the method proposed by Cole et al. (2010).
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2.0 OUR PROPOSED METHOD
2.1 INTRODUCTION
Robins (1998) introduced the marginal structural models which included the marginal struc-
tural Cox proportional hazards model. He proved that the estimator from the marginal
structural models is a regular linear estimator and therefore it is an unbiased estimator.
Herna´n et al. (2000) demonstrated how to use the marginal structural Cox proportional
hazards model with an example of estimating the causal effect of Zidovudine on mortality
for patients with HIV infection.
For each treatment history a¯ the hazard of the marginal structural Cox proportional
hazards model has the form
λTa¯(t|V ) = λ0(t) exp[β1g{a¯(t)}+ β2V ],
where a¯ denotes treatment history, g(.) is a known function, Ta¯ denotes a subject’s coun-
terfactual event time had he followed treatment history a¯, V denotes the vector of baseline
covariates, λTa¯(t|V ) denotes hazard of the event at time t for subjects with covariate V in the
population had all subjects followed a¯ through time t, λ0(t) denotes a unspecified baseline
hazard of the event, and β1 and β2 denote parameters which need to be estimated.
In practice, fitting the marginal structural Cox proportional hazards model is equiva-
lent to fitting a weighted time-dependent Cox proportional hazards model, λT (t|A¯(t), V ) =
λ0(t) exp[γ1g{A¯(t)}+ γ2V ] by assigning subject i at time j a weight wij = wAij × wCij , where
A(t) is the actual treatment at time t, A¯(t) is the actual treatment history up to time t,
λT (t|A¯(t), V ) is the conditional hazard of the event given the actual treatment history A¯(t)
and baseline covariate V , and γ1 and γ2 are the parameters to be estimated. The weight W
A
ij
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denotes the inverse probability treatment weight and WCij denotes the inverse probability
censoring weight and can be calculated as follows, respectively
wAij =
j∏
k=0
pr{A(k) = ai(k)|A¯(k − 1) = a¯i(k − 1), V = vi}
pr{A(k) = ai(k)|A¯(k − 1) = a¯i(k − 1), L¯(k) = l¯i(k)}
,
wCij =
j∏
k=0
pr{C(k) = 0|C¯(k − 1) = 0, A¯(k − 1) = a¯i(k − 1), V = vi}
pr{C(k) = 0|C¯(k − 1) = 0, A¯(k − 1) = a¯i(k − 1), L¯(k − 1) = l¯i(k − 1)}
.
2.2 NOTATIONS AND MODELS
Let Z be the true treatment, X be the patient self-reported treatment, Dk be the set of
subjects who experienced the event at time k, Rk be the set of subjects who were at risk
right before time k, g(x¯ik) be the proportion of treated time reported by patient i among
the first k times, Wik be the weight for subject i at time k, γ1 be the coefficient in the model
E(Z|X) = γ0 +γ1X indicating the relation between Z and X, θ be the true treatment effect
which we are interested in and will be estimated, and β be the self-reported treatment effect.
In order to estimate the causal effect of the treatment Z, we fit a weighted time-dependent
Cox model directly and suggest using the Breslow-type Breslow (1974) weighted partial
likelihood for β:
Lp(β) =
K∏
k=1
exp{β∑Dk Wikg(x¯ik)}
[
∑
Rk
Wik exp{βg(x¯ik)}]
∑
Dk
Wik
.
Since the relationship θ = β/γ1 holds in Cox proportional hazards model under certain
conditions Spiegelman et al. (1997), by knowing the partial likelihood of β, the partial
likelihood for θ becomes
Lp(θ) =
∂(γ1θ)
∂θ
K∏
k=1
exp{γ1θ
∑
Dk
Wikg(x¯ik)}
[
∑
Rk
Wik exp{γ1θg(x¯ik)}]
∑
Dk
Wik
= γ1
K∏
k=1
exp{γ1θ
∑
Dk
Wikg(x¯ik)}
[
∑
Rk
Wik exp{γ1θg(x¯ik)}]
∑
Dk
Wik
= γ1
K∏
k=1
exp[θ
∑
Dk
Wik{γ1g(x¯ik)}]
(
∑
Rk
Wik exp[θ{γ1g(x¯ik)}])
∑
Dk
Wik
,
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which is the Breslow-type partial likelihood with γ1g(x¯ik) as the regressor.
To estimate γ1 in LP (θ) when a validation data set is not available, we define the correct-
classification rates and the marginal probability of being actually treated as follows
η1 = P (X = 1|Z = 1),
η2 = P (X = 0|Z = 0),
where η1 and η2 can be viewed as the probability of correctly identifying those treated
patients and the probability of correctly identifying those untreated patients, respectively.
We also define the marginal probability of being actually treated as
pi = P (Z = 1).
McGlothlin et al. (2008) have defined these probabilities in order to correct the
effect of misclassification in outcome in the logistic regression model when the outcome was
misclassified and one of the predictors was measured with error.
With these three probabilities, we can calculate the following two probabilities:
ψ1 = P (Z = 1|X = 1) = η1 × pi
η1 × pi + (1− η2)× (1− pi) ,
ψ2 = P (Z = 0|X = 0) = η2 × (1− pi)
η2 × (1− pi) + (1− η1)× pi ,
where ψ1 and ψ2 can be viewed as the probability of self-reported treated that are actually
treated and the probability of self-reported untreated that are actually untreated.
Simulation evidences in the studies of Cole et al. (2006) and Spiegelman et al. (2000)
suggest that it is appropriate to use the model E(Zi|Xi) = γ0 + γ1Xi to represent the
relation between the self-reported treatment X and the true treatment Z. From this model,
E(Z|X) = γ0 + γ1X for X = 0 and X = 1. Note that E(Z|x = 0) = P (z = 1|x = 0) =
1 − P (z = 0|x = 0) = 1 − ψ2 and E(Z|x = 1) = P (z = 1|x = 1) = ψ1. It is evident that
γ1 = E(Z|x = 1) − E(Z|x = 0) = ψ1 + ψ2 − 1. Figure 4 depicts these relations. Once pi is
specified, one can estimate η1 and η2, then ψ1 and ψ2, and then γ1.
If η1 and η2 are unknown, we can postulate prior distributions of η1 and η2 to estimate
the uncertainties. We then will combine these prior distributions with the observed data to
estimate the parameter through the Bayesian approach.
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2.3 ESTIMATION
We let parameters η1 and η2 follow the prior distribution. η1 ∼ beta(a1, b1), η2 ∼ beta(a2, b2),
respectively, and let parameter θ ∼ N(µ0, σ20), where the information about a1, b1, a2, b2 can
be calculated based on the mean and the variance of η1 and η2, and the mean and the
variance of η1 and η2 can be estimate from the median and the range of η1 and η2. Hozo
et al. (2005) developed a method to estimate the mean and variance from the median and
the range. We assume this information can be obtained from a pilot study or from experts.
Since little is known about θ, we set µ0 = 0 and use a large value of σ
2
0 (e.g. σ
2
0 = 100).
If η1, η2, and θ are independent, the joint posterior distribution of η1, η2, and θ is
P (θ, η1, η2|g(x¯ik), t) ∝ γ1
K∏
k=1
exp{γ1θ
∑
Dk
Wikg(x¯ik)}
[
∑
Rk
Wik exp{γ1θg(x¯ik)}]
∑
Dk
Wik
×
ηa11 (1− η1)b1−1 × ηa22 (1− η2)b2−1 × exp{−
(θ − µ0)2
σ20
}
where γ1 =
η1×pi
η1×pi+(1−η2)×(1−pi) +
η2×(1−pi)
η2×(1−pi)+(1−η1)×pi − 1
In order to estimate η1, η2, and θ, we randomly sampled η1, η2, and θ from their joint
posterior distribution, and estimated η1, η2, and θ by taking their average values, respectively.
The joint posterior distribution of η1, η2, and θ is not a standard density, so it is difficult to
sample η1, η2, and θ from it. Markov chain Monte Carlo (mcmc) is particularly useful in this
situation. The essence of mcmc is to create a Markov chain which will typically converge to
the desired posterior distribution over the simulation after a large number of iterations, then
the draws from Markov chain are approximately from the posterior distribution. We use
the mcmc package in R 3.0.2 to implement the simulation. mcmc is a package which allows
users to create Markov chain via metropolis algorithm without writing their own code.
Let P (θ|x) be the posterior distribution of the parameter θ. Metropolis algorithm works
as follows.
1. Choose initial value θ0 for θ with P (θ0|x) > 0.
2. At iteration t, draw the candidate θ∗ from the proposal distribution Jt(θ∗|θt−1).
3. Calculate the acceptance ratio r = P (θ∗|x)/P (θt−1|x).
4. Accept θ∗ with probability min(r, 1), otherwise θt = θt−1.
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5. Repeat step 2 to step 4 N times, where N is a large number (e.g. N = 10, 000).
In order to use mcmc package, one has to specify the initial values of the parameters
and the logarithm of unnormalized posterior distribution which equals to the logarithm of
likelihood plus logarithm of prior distribution. At iteration t, the software draws a candidate
of parameters from the proposed distribution which is a multivariate normal distribution,
calculates the acceptance ratio, and determines whether the candidate of parameters should
be accepted. The output is an m × p matrix with each element the mean of batch, where
batch is a segment of the Markov chain with certain length (e.g. the kth batch can be
θk+1, . . . , θk+b, m is the number of batches and p is the dimension of parameters. The overall
estimator of each parameter is obtained by calculating the associated column mean of the
matrix. For example, if there are two parameters, θ and γ, to be estimated, the output will
be as follows 
θ1 γ1
... ...
θm γm
 ,
where the batch mean θ1 is the average value of the first batch θ
1, . . . , θb, and θm is the
average value of the last batch θ(m−1)b+1, . . . , θ(m−1)b+b. The overall estimated θ is θˆ =
(θ1 + . . .+ θm)/m. Parameter γ is estimated with the same method.
2.4 VARIANCE CALCULATION
In order to make the hypothesis test feasible, we constructed the variance estimator of the
estimated treatment causal effect θˆ from our proposed method. Rosner et al. (1989) provided
a formula to calculate the variance of θˆ where θˆ = βˆ/γˆ1 and βˆ is the estimated self-reported
treatment effect. βˆ and var(βˆ) can be obtained from the standard marginal structural Cox
model with the self-reported treatment as the predictor. In their study, γˆ1 and var(γˆ1) are
estimated by fitting a linear regression model using a validation data set. Because we do not
have a validation data set, we are not able to use their strategy to construct the variance
estimator. We estimated γˆ1 and var(γˆ1) based on the Bayesian Central Limit Theorem.
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The idea is described below. Let α = (θ, γ1), αˆ be the MLE of α, H be the observed
Fisher information matrix, and Σ = H−1. The Bayesian Central Limit Theorem states that
when sample size is large, the posterior distribution of α, P (α|x), is approximately normally
distributed N(αˆ,Σ) where x denotes the data. In our study, the joint likelihood function of
θ and γ1 is
Lp(θ) = γ1
K∏
k=1
exp{γ1θ
∑
Dk
Wikg(x¯ik)}
[
∑
Rk
Wik exp{γ1θg(x¯ik)}]
∑
Dk
Wik
,
θ and γ1 cannot be estimated simultaneously from this partial likelihood directly because
that two different sets of θ and γ1 may lead to the same likelihood, and thus they are not
identifiable. Therefore, we estimated θ using the proposed method we described above and
substituted θ by its estimator θˆ, then we calculated the mean and the variance of γ1, and
then substituted these values into the formula of
var(θˆ) = (1/γˆ1
2)var(βˆ) + (βˆ2/γˆ1
4)var(γˆ1)
provided by Rosner et al. (1989).
2.5 SIMULATION
2.5.1 Simulation Setting
Figure 5 was adapted based on “Appendix Figure 1” in Cole et al. (2010). It illustrates the
relationship among variables in our simulated data sets. Because that the true treatment
Z has causal effects on the time-dependent confounder L and the self-reported treatment
X and that L has causal effect on survival time T , Z has indirect causal effect on T . Self-
reported treatment X does not have causal effect on T given Z. We generated simulation
data sets based on Figure 5. A detailed specification is described as follows:
1. True treatment at time 0: Z0 ∼ Bernoulli(0.5).
2. True treatment at time 1: Z1|L = 1 ∼ Bernoulli(0.7), Z1|L = 0 ∼ Bernoulli(0.3).
3. Self-reported treatment at time 0: X0|Z0 = 1 ∼ Bernoulli(η1), X0|Z0 = 0 ∼
Bernoulli(1− η2).
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4. Self-reported treatment at time 1: X1|Z1 = 1 ∼ Bernoulli(η1), X1|Z1 = 0 ∼
Bernoulli(1− η2).
5. Time-dependent confounder: L|Z0 = 1 ∼ Bernoulli(0.7), L|Z0 = 0 ∼ Bernoulli(0.3).
P (L = 1) ' 0.5.
6. Survival time: T ∼ Exp(λ) with λ = λ0 exp(αL), where α = −0.7, λ0 was set to make
the risk of event 0.15, 0.25, 0.35.
7. Censoring time was generated from the uniform distribution. The parameters were set
to make censoring rate 0, 0.15, 0.3.
8. η1 = 0.9, η2 = 0.8, and pi = 0.5, where η1 and η2 are the probabilities of actually treated
and untreated patients who are correctly identified. pi is the marginal probability of
being actually treated.
9. The parameter of the true treatment effect on the survival time T was calculated using
the method of Cole et al. (2010). As described above, the true treatment Z0 has an
indirect effect on the survival time T through L, therefore, in this step, we treat L as
the true predictor of the survival time T and treat Z0 as the “misclassified” predictor.
We use θ to denote the parameter of treatment effect, which has to be calculated in this
step, and use α to denote the effect of L, which we have already set to be −0.7. In order
to estimate γ1 in the method of Cole et al. (2010), we simulated 100 data sets with each
containing 100, 000 observations and fitted the linear model E(L|Z0) = γ0 +γ1Z0 in each
data set. The estimated γ1 is the average of γ1 obtained from the above linear model
fitted in each data set. γ1 = 0.3997. θ = α ∗ γ1 = −0.7 ∗ 0.3997 = 0.27979 ≈ −0.28.
We simulated 500 data sets each containing 1000, 2000, and 3000 subjects. For each of
the simulated data set, we performed two analyses to estimate the causal effect of treatment
on mortality and compared results obtained from these two methods. First, we performed the
naive analysis using the observed treatment assignments as the predictor without correcting
for possibly misclassified treatment assignments. This was fitted via a standard marginal
structural Cox model. Then we applied the proposed method to obtain the bias-corrected
causal effect of treatment on mortality. The estimated treatment effect is calculated as the
average of the estimated treatment effect obtained from each data set. We also calculated
the standard error of the estimated treatment effect which is the square root of the average
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of the variance estimated from each data set, and the coverage probability which is the
proportion that the confidence interval contains the true parameter, which is −0.28 in our
simulation study.
In order to examine the impacts of the prior distributions of η1 and η2 on the estimators
of the treatment causal effect, we performed the sensitive analysis. Specifically, besides the
beta distribution, we also assume η1 and η2 follow uniform distribution. The parameters of
uniform distribution can be calculated based on the mean and the variance of η1 and η2. For
these two types prior distribution, we shifted down η∗1, the mean of the prior distribution
of η1, by 5%, 10% and shifted up η
∗
2, the mean of the prior distribution of η2, by 5%, 10%
from the original settings of η1 and η2, respectively. We also shifted η
∗
1 and η
∗
2 in the same
direction (down or up) by 5% simultaneously.
In all simulations, we set the number of batch to 1000 and the length of batch to 10.
2.5.2 Simulation Results
We performed simulations in different scenarios with combinations of different event rates,
censoring rates, and values of η∗1 and η
∗
2. Simulation results that are presented in Table 1
to Table 3 were estimated from the sample containing 3, 000 observations in 45 scenarios
with beta prior distribution for η1 and η2. Simulation results that are presented in Table
4 to table 6 were estimated from the sample with the same size in the same scenarios but
with uniform prior distribution for η1 and η2. The naive estimate is always biased severely
toward 0. Either high event risk (≥ 35%) or high censoring rate (≥ 30%) bias the estimated
treatment effect toward 0 regardless the prior distribution, but the bias is moderate (≤ 10%)
if only one of these two factors exists. However, if both the event risk and the censoring
rate are high, our proposed method gives a biased estimate but is still better than the naive
estimate. In general, if the high risk of event and the high censoring rate are not present at
the same time, our method reduces bias of the estimate greatly in the following settings:
1. let η∗1 and η
∗
2 be the original settings of η1 and η2, respectively.
2. shift η∗1 down from η1 by 5% and η
∗
2 up from η2 by 5%.
3. shift η∗1 down from η1 by 10% and η
∗
2 up from η2 by 10%.
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However, when both of η∗1 and η
∗
2 are shifted from the original settings of η1 and η2 in the
same direction by 5% simultaneously, our proposed method gave a biased estimate which is
less biased as compared with the naive estimate.
In all scenarios, the estimated coverage probability is lower than 95%, which is the target
value we expected to achieve. The coverage probability increases when the event risk and
the censoring rate are high. The coverage probability also increases with the sample size
becoming large. For example, the coverage probability is 0.724 for the sample with size 1000
in the setting that the event risk is equal to 15%, censoring rate is equal to 0, η∗1 is equal to
0.9, and η∗2 is equal to 0.8, it increases to 0.796 if the sample size is 2000, and increases to
0.86 if the sample size is 3000.
Our simulation results also show that if the sample size is small (e.g. 1000), although
the estimated treatment effect generally shows the trend we described above using the large
sample (e.g. 3000), the estimated treatment effect in some scenarios is abnormal, reflecting
that the simulation results are not very stable. For example, in the setting that both the
event risk and censoring rate are equal to 15%, η∗1 is equal to 0.9, and η
∗
2 is equal to 0.8, the
estimated treatment effect is −0.253, which is biased, whereas the corresponding estimator
from a large sample is very close to the true parameter. In the scenario that the event risk
and censoring rate are 15%, shifting up η∗1 and η
∗
2 by 5%, results in a estimated treatment
effect of −0.263, which is “accurate”, whereas, shifting up η∗1 and η∗2 by 5% simultaneously
bias the estimated treatment effect toward 0 in all settings when the sample size is large.
When the sample size is small (e.g. < 1, 000), the estimated treatment effect from each
simulation data set could spread widely around the true parameter, about 10% of the estima-
tors were positive, which were in the opposite direction of the true parameter value. When
the sample size becomes larger (e.g. 2, 000), it is less likely that the estimated treatment
effect from data sets are positive, but they still spread widely around the true parameter.
The estimated treatment effect becomes more concentrate around the true parameter with
the sample size increasing. Figure 6 and Figure 7 show this phenomenon in 2 different
scenarios: scenario 1 was set the event risk to 0.15, censoring rate to 0, η∗1 to 0.9, and η
∗
2 to
0.8; scenario 2 was set the event risk to 0.35, censoring rate to 0.3, η∗1 to 0.9, and η
∗
2 to 0.8.
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The estimates of η1 and η2 from the posterior distribution are almost equivalent to the
mean of the prior distribution of η1 and η2, respectively, showing that the data have little
impact on the estimates.
2.6 EXAMPLE
Human immunodeficiency virus (HIV) infection presents one of the challenges in disease
treatment worldwide. Center for Disease Control and Prevention (CDC) estimates that in
the United States there were 1, 148, 200 people who had been infected with HIV by the
end of 2009, 15, 529 people who diagnosed of AIDS died in 2010, and 32, 052 people were
diagnosed with AIDS in 2011 CDC (2011). Highly active antiretroviral therapy (HAART)
was introduced in 1996, and many studies showed that it delays the progression to AIDS
Wong et al. (2004) and also prolongs the survival among HIV infected patients Wong et al.
(2004), Tam et al. (2002). However, these studies either failed to take the time-dependent
confounder into account Wong et al. (2004), Tam et al. (2002) or assumed that once patients
received the treatment, they would stay in the treatment Sterne et al. (2005). Moreover,
none of these studies calibrated the recorded treatment for possible measurement errors. Our
interest lies in estimating the net effect of HAART on the onset of AIDS or death among
HIV-positive patients realistically by calibrating for the measurement error in the observed
treatment and accounting for the dropout of patients from the treatment.
We applied our proposed method to the data which are from the multicenter AIDS
Cohort Study (MACS) and Womens Interagency HIV Study (WIHS). Data in these two
studies were collected from physical examination, blood test, and questionnaire which were
conducted every six months on the patients. The period of analysis is from January 1996,
soon after the Food and Drug Agency (FDA) approved HAART in December 6, 1995, to the
end of 2007.
In our analysis, we included 651 patients who were alive, HIV-positive, without clinical
AIDS, and not using non-HAART antiretroviral therapy at the first visit of 1996. Among
them, 205 participants developed clinical AIDS or died, and 581 participants reported that
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they administrated HAART. There were 651 patients accounted for 2, 136 person-visits which
is equal to 1, 068 person-visits/year. The median follow-up time is 1.5 years.
The baseline covariates include the age at the first visit, gender, CD4 cell counts (<
200, 200− 350, 351− 500, and > 500), and viral load (≤ 4000, 4001− 10, 000, and > 10, 000).
The treatment history in the weight calculation at time k includes Xk−1, Xk−2, Xk−3, and
the covariate histories are the restricted cubic splines of CD4 cell counts and logarithm to
base 10 of viral load at time k − 1 with the knots at 5, 33, 67, 95 percentiles.
The parameters of the beta prior distribution of the classification rates were calculated
based on the validation sub-study described in Cole et al. (2010). Specifically, η1, the prob-
ability of actually treated patients who were correctly identified, was equal to 0.84 and its
standard deviation was equal to 0.02. The parameters of the prior distribution of η1 were
252 and 48. η2, the probability of actually untreated patients who are correctly identified
was 0.8 and its standard deviation was 0.04. The parameters of the prior distribution of η2
were 80 and 20. We used the proportion of the truly treated patient as the prevalence of
treatment. In order to assess the impact on the choice of the prior distribution of the correct
classification rates, we shifted these two means in different direction by 5% and 10%. For
comparison, we also performed analyses using the standard marginal structural Cox model.
The results are presented in Table 7.
Both the proposed method and the standard marginal structural Cox model identified
that HAART prolongs the time to developing clinical AIDS or the survival time among
HIV-positive patient. However, the standard marginal structural Cox proportional hazards
model biased the estimated coefficient down to 0 severely. Cole et al. (2010) summarized
the previous similar studies and stated that the range of the estimated treatment effect was
from 0.14 to 0.54. The estimate from the proposed method falled in that range, but the
naive estimate did not. The results also show that the choice of the prior distribution of the
correct-classification rates has little impact on the estimated treatment effect.
In practice, one may only have the range and the median of η1 and η2, the method of
Hozo et al. (2005) can be used to estimate the mean and the variance of η1 and η2, which
are required for estimating the parameters of the prior distribution. The range of η1 and η2
can be validated using the data from pilot study or the information from literatures. If none
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of the information is available, one still can expect to obtain the estimated treatment effect
with small bias given the prior mean of η1 and η2 are not biased in the same direction.
In this example, the sample size was 651 patients, but our simulation results suggest that
small sample size (e.g. 1000) might result in unstable estimate. Our goal is to demonstrate
the application of the proposed method and this is the only data set which is available for us.
In order to obtain a relative stable estimates, we set the number of batches to 100000, and
the batch length to 10. We repeated the analysis 10 times and all the estimated coefficients
of treatment effect were very close to −0.82.
2.7 CONCLUSIONS AND DISCUSSION
In this study, we incorporated the Bayesian method and the regression calibration method
into the marginal structural Cox models to develop a new approach which will allow us to
estimate the causal effect of treatment on the survival with possibly misclassified treatment.
Our proposed method extends the work of Cole et al. (2010) which required a validation data
set whereas a validation data set is not needed in our study. We use the prior distribution to
capture the uncertainty about the correct-classification rates. Our simulation results show
that even though the mean of the prior distribution of the correct-classification rates is differ-
ent from the true underlying correct-classification rates, our proposed method still provides
an estimate which is close to the true treatment effect in various scenarios. Therefore, no pa-
rameters are assumed known exactly when applying our proposed method. This will have a
significant impact on statistical analysis. Before our studies, it was difficult for investigators
to account for measurement error without having a validation set because that a validation
data set was often used for correcting bias in the estimate caused by measurement error
in the predictor. Our proposed method offers a new approach in causal inference which is
particularly useful when the investigator has little information about the measurement error
and a validation data set is unavailable.
It is worth noting that our simulation results also show that our proposed method will
greatly reduce bias in estimating the true treatment effect at a cost of precision. Nevertheless,
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just as what Carroll (2011) indicated in his lecture, no strategy can relieve this caveat thus
far. The mean squared error (MSE) of the estimate could be larger in our proposed method
than that in the naive method. Thus, we do not suggest to use our proposed method if the
effect of the predictor is expected to be small since bias corrected is finite, but the variance
of the estimate is inflated.
The bias of the estimation from our proposed method is larger when the risk of event is
high (≥ 35%), as compared with that when the risk of event is low. This result coincides with
the studies of Prentice (1982) and Rosner et al. (1989), which required that the event risk is
low or the disease is rare. Spiegelman et al. (1997) also stated that the relationship θˆ = βˆ/γˆ1
holds in a Cox model under the assumption of low event rate. Andersen and Liestøl (2003)
did a simulation study to assess the impact of high risk of event on the estimate of treatment
effect and found that high event rate could be another attenuating factor in estimation under
the Cox model framework, but the effect is moderate.
Our simulation results show that small sample size might result in unstable estimates
and the estimated treatment effect obtained from simulation data sets could spread widely
around the true parameter. Therefore, one would expect a large variance in the estimate
and thus a lower statistical power when the sample size is small. This feature might restrict
the application of our proposed method to data with a large sample. However, just as what
we showed in the above example, the investigator might obtain a relatively stable estimate
by increasing the number of batches.
The difference between the naive estimated treatment effect and the estimate from our
proposed method is close to βˆ(1− 1/γ1), but not close to βˆ(1− 1/γˆ1) in the scenarios which
the event risk and censoring are low and the proposed method works well. For example,
in the scenario that event risk is equal to 0.15, the censoring rate is equal to 0, and both
η∗1 and η
∗
2 are equal to 0.85, the difference between the naive estimate and our estimate
is 0.077, βˆ(1 − 1/γ1) is 0.085, but βˆ(1 − 1/γˆ1) is −0.02. This is because γˆ1 obtained by
maximizing Lp(θ) with θ replaced by θˆ is 1.13, which should be about 0.707. In general,
our method does not estimate γ1 accurately. However, the var(θˆ) calculated using the
information of βˆ, var(βˆ), γˆ1, var(γˆ1) is close to the empirical estimate when the event risk is
low (e.g. < 35%.)
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Although the estimated treatment effect from our proposed method is much less biased
as compared with that from the naive estimate, the bias is still significant after shifting
the mean of the prior distribution of η1 and η2 from the original settings of η1 and η2 in
the same direction by 5% simultaneously. Moreover, the estimates of η1 and η2 from their
posterior distributions were not updated from the data, so the estimates depended on their
prior settings.
Besides misclassification in the treatment, there are other factors which could bias toward
0 in estimating the treatment causal effect on survival. Andersen and Liestøl (2003) showed
that in longitudinal studies, non-synchronously updating the measurements of variables and
ageing can also attenuate the estimated predictor effect. In this study, we only took treatment
misclassification into consideration.
In applying the method of Cole et al. (2010), there are two sources of restriction in low
event rate. The first one requires low event rate in the regression calibration method. Rosner
et al. (1989) proved that θˆ = βˆ/γˆ1 holds in logistic regression when the event rate is low, and
the measurement error is small and non-differential. Spiegelman et al. (1997) stated that
the same relationship holds in Cox proportional hazards model under the assumptions that
the event rate is low, the measurement error is small and non-differential, and the censoring
is non-informative. The second source of requirement of low event rate was established
when, using a pooled logistic regression model to approximate a weighted time-dependent
Cox model. D’Agostino et al. (1990) showed that the estimator from the pooled logistic
regression is close to that from the Cox proportional hazards model when the event rate is
low. Cole et al. (2010) stated that their method works well when the event rate in each
time interval is less than 10%. In applying our proposed method, we can fit a marginal
structural Cox model directly via the input data with the counting process style of Fleming
and Harrington (1991). This will then remove the restriction of low event rate from the
second source so that the allowable event rate is expected to exceed 10% when using our
proposed method. The simulation results of our proposed method show that the allowable
event rate increases to at least 25%.
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Figure 1: Difference between causation and association.
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APPENDIX: TABLES AND FIGURES
Figure 2: Conditions under which standard methods fail to give consistent estimate.
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Figure 3: Underlying idea of marginal structural models.
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Figure 4: Relation between the true treatment and observed treatment.
30
Figure 5: Variables relationship in simulated data set.
31
Figure 6: Comparison of dispersion of the estimated treatment effect in different sample size
in scenario 1
32
Figure 7: Comparison of dispersion of the estimated treatment effect in different sample size
in scenario 2
33
Table 1: Simulation results with beta prior distribution of parameter comparing the bias, the
Monte Carlo standard error (MCSE), the standard deviation estimates (SD), the coverage
probability (95%) of the different analysis methods when the event risk is low (15%)
Proposed method Naive method
risk, censoring, η∗1, η∗2 Bias MCSE SD CP Bias MCSE SD CP
0.15, 0.00, 0.90, 0.80 0.0025 0.1476 0.1496 0.8600 0.0760 0.1073 0.1078 0.8860
0.15, 0.00, 0.85, 0.85 -0.0011 0.1521 0.1511 0.8640 0.0757 0.1096 0.1079 0.8880
0.15, 0.00, 0.80, 0.90 0.0049 0.1498 0.1489 0.8720 0.0776 0.1073 0.1080 0.8980
0.15, 0.00, 0.85, 0.75 -0.0470 0.1811 0.1773 0.8840 0.0758 0.1118 0.1077 0.8920
0.15, 0.00, 0.95, 0.85 0.0498 0.1275 0.1278 0.8080 0.0855 0.1073 0.1079 0.8740
0.15, 0.15, 0.90, 0.80 0.0188 0.1476 0.1487 0.8500 0.0881 0.1073 0.1118 0.8860
0.15, 0.15, 0.85, 0.85 0.0119 0.1543 0.1511 0.8560 0.0850 0.1118 0.1118 0.8880
0.15, 0.15, 0.80, 0.90 0.0174 0.1610 0.1491 0.8120 0.0870 0.1185 0.1120 0.8640
0.15, 0.15, 0.85, 0.75 -0.0449 0.1878 0.1792 0.8700 0.0761 0.1163 0.1120 0.8840
0.15, 0.15, 0.95, 0.85 0.0297 0.1230 0.1361 0.8780 0.0695 0.1006 0.1118 0.9340
0.15, 0.30, 0.90, 0.80 0.0184 0.1610 0.1532 0.8360 0.0870 0.1185 0.1163 0.8900
0.15, 0.30, 0.85, 0.85 0.0080 0.1655 0.1569 0.8340 0.0818 0.1185 0.1162 0.8860
0.15, 0.30, 0.80, 0.90 0.0067 0.1521 0.1556 0.8480 0.0790 0.1118 0.1159 0.8960
0.15, 0.30, 0.85, 0.75 -0.0294 0.1789 0.1796 0.8560 0.0860 0.1118 0.1159 0.9120
0.15, 0.30, 0.95, 0.85 0.0408 0.1498 0.1350 0.8020 0.0781 0.1252 0.1161 0.8700
Bias=estimated treatment effect−(−0.28); η∗1 : mean of the prior distribution of η1; η∗2 : mean of the
prior distribution of η2;
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Table 2: Simulation results with beta prior distribution of parameter comparing the bias, the
Monte Carlo standard error (MCSE), the standard deviation (SD), the coverage probability
(95%) of the different analysis methods when the event risk is moderate (25%)
Proposed method Naive method
risk, censoring, η∗1, η∗2 Bias MCSE SD CP Bias MCSE SD CP
0.25, 0.00, 0.90, 0.80 0.0171 0.1096 0.1276 0.9060 0.0827 0.0813 0.0825 0.8380
0.25, 0.00, 0.85, 0.85 0.0027 0.1140 0.1309 0.9220 0.0850 0.0728 0.0825 0.8380
0.25, 0.00, 0.80, 0.90 0.0111 0.1118 0.1284 0.9100 0.0827 0.0763 0.0825 0.8380
0.25, 0.00, 0.85, 0.75 -0.0305 0.1342 0.1494 0.9260 0.0850 0.0796 0.0824 0.8320
0.25, 0.00, 0.95, 0.85 0.0520 0.0984 0.1111 0.8760 0.0819 0.0850 0.0825 0.8440
0.25, 0.15, 0.90, 0.80 0.0202 0.1051 0.1304 0.9100 0.0821 0.0850 0.0856 0.8680
0.25, 0.15, 0.85, 0.85 0.0224 0.1163 0.1298 0.8980 0.0863 0.0872 0.0856 0.8200
0.25, 0.15, 0.80, 0.90 0.0194 0.1163 0.1296 0.9100 0.0819 0.0872 0.0855 0.8480
0.25, 0.15, 0.85, 0.75 -0.0248 0.1297 0.1528 0.9240 0.0829 0.0850 0.0855 0.8500
0.25, 0.15, 0.95, 0.85 0.0598 0.0939 0.1119 0.8660 0.0875 0.0805 0.0855 0.8440
0.25, 0.30, 0.90, 0.80 0.0194 0.1118 0.1285 0.8880 0.0785 0.0872 0.0834 0.8260
0.25, 0.30, 0.85, 0.85 0.0225 0.1140 0.1287 0.8920 0.0872 0.0830 0.0834 0.8200
0.25, 0.30, 0.80, 0.90 0.0229 0.1118 0.1284 0.9040 0.0815 0.0872 0.1159 0.8340
0.25, 0.30, 0.85, 0.75 -0.0297 0.1230 0.1521 0.9380 0.0758 0.0805 0.0834 0.8540
0.25, 0.30, 0.95, 0.85 0.0529 0.0984 0.1121 0.8720 0.0783 0.0872 0.0834 0.8520
Bias=estimated treatment effect−(−0.28); η∗1 : mean of the prior distribution of η1; η∗2 : mean of the
prior distribution of η2;
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Table 3: Simulation results with beta prior distribution of parameter comparing the bias, the
Monte Carlo standard error (MCSE), the standard deviation (SD),the coverage probability
(95%) of the different analysis methods when the event risk is high (35%)
Proposed method Naive method
Bias MCSE SD CP Bias MCSE SD CP
risk, censoring, η∗1, η∗2 (mcse) (mcse) (mcse) (mcse) (mcse) (mcse)
0.35, 0.00, 0.90, 0.80 0.0232 0.0872 0.1167 0.9460 0.0788 0.0693 0.0702 0.8040
0.35, 0.00, 0.85, 0.85 0.0178 0.0962 0.1179 0.9200 0.0767 0.0760 0.0701 0.7940
0.35, 0.00, 0.80, 0.90 0.0285 0.0872 0.1156 0.9300 0.0831 0.0671 0.0701 0.7680
0.35, 0.00, 0.85, 0.75 -0.0138 0.0984 0.1357 0.9580 0.0834 0.0671 0.0700 0.7900
0.35, 0.00, 0.95, 0.85 0.0566 0.0783 0.1015 0.8940 0.0789 0.0693 0.0700 0.7980
0.35, 0.15, 0.90, 0.80 0.0186 0.0917 0.1195 0.9280 0.0737 0.0738 0.0719 0.8160
0.35, 0.15, 0.85, 0.85 0.0197 0.0894 0.1204 0.9520 0.0761 0.0693 0.0718 0.8240
0.35, 0.15, 0.80, 0.90 0.0362 0.0894 0.1163 0.9260 0.0872 0.0693 0.0719 0.7580
0.35, 0.15, 0.85, 0.75 -0.0114 0.1073 0.1374 0.9480 0.0839 0.0716 0.0718 0.7840
0.35, 0.15, 0.95, 0.85 0.0602 0.0783 0.1030 0.8760 0.0804 0.0693 0.0719 0.7940
0.35, 0.30, 0.90, 0.80 0.0357 0.0939 0.1187 0.9220 0.0844 0.0738 0.0737 0.7820
0.35, 0.30, 0.85, 0.85 0.0311 0.0962 0.1199 0.9000 0.0827 0.0760 0.0737 0.7860
0.35, 0.30, 0.80, 0.90 0.0263 0.0939 0.1206 0.9120 0.0774 0.0738 0.0737 0.8120
0.35, 0.30, 0.85, 0.75 -0.0158 0.1073 0.1415 0.9440 0.0787 0.0738 0.0737 0.7920
0.35, 0.30, 0.95, 0.85 0.0582 0.0783 0.1052 0.9020 0.0766 0.0716 0.0737 0.8300
Bias=estimated treatment effect−(−0.28); η∗1 : mean of the prior distribution of η1; η∗2 : mean of the
prior distribution of η2;
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Table 4: Simulation results with uniform prior distribution of parameter comparing the
bias, the Monte Carlo standard error (MCSE), the standard deviation estimates (SD), the
coverage probability (95%) of the different analysis methods when the event risk is low (15%)
Proposed method Naive method
risk, censoring, η∗1, η∗2 Bias MCSE SD CP Bias MCSE SD CP
0.15, 0.00, 0.90, 0.80 0.0001 0.1497 0.1512 0.8740 0.0763 0.1082 0.1080 0.8960
0.15, 0.00, 0.85, 0.85 0.0078 0.1640 0.1502 0.8320 0.0829 0.1179 0.1081 0.8580
0.15, 0.00, 0.80, 0.90 0.0110 0.1448 0.1487 0.8580 0.6032 0.1044 0.1080 0.8820
0.15, 0.00, 0.85, 0.75 -0.0356 0.1745 0.1739 0.8560 0.0822 0.1079 0.1078 0.8700
0.15, 0.00, 0.95, 0.85 0.0383 0.1326 0.1314 0.8280 0.0782 0.1098 0.1080 0.8860
0.15, 0.15, 0.90, 0.80 0.0198 0.1510 0.1495 0.8460 0.0890 0.1096 0.1118 0.8840
0.15, 0.15, 0.85, 0.85 0.0135 0.1498 0.1518 0.8460 0.0864 0.1077 0.1119 0.8860
0.15, 0.15, 0.80, 0.90 0.0034 0.1477 0.1540 0.8640 0.0773 0.1073 0.1120 0.9000
0.15, 0.15, 0.85, 0.75 -0.0454 0.1920 0.1791 0.8640 0.0763 0.1192 0.1116 0.8980
0.15, 0.15, 0.95, 0.85 0.0402 0.1390 0.1332 0.8040 0.0777 0.1149 0.1119 0.8800
0.15, 0.30, 0.90, 0.80 0.0014 0.1572 0.1564 0.8520 0.0751 0.1148 0.1161 0.9140
0.15, 0.30, 0.85, 0.85 0.0109 0.1626 0.1558 0.8440 0.0848 0.1159 0.1160 0.8960
0.15, 0.30, 0.80, 0.90 0.0112 0.1673 0.1550 0.8300 0.0837 0.1218 0.1162 0.8740
0.15, 0.30, 0.85, 0.75 -0.0335 0.1988 0.1800 0.8240 0.0833 0.1237 0.1162 0.8620
0.15, 0.30, 0.95, 0.85 0.0469 0.1324 0.1333 0.8160 0.0832 0.1114 0.1160 0.9040
Bias=estimated treatment effect−(−0.28); η∗1 : mean of the prior distribution of η1; η∗2 : mean of the
prior distribution of η2;
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Table 5: Simulation results with uniform prior distribution of parameter comparing the
bias, the Monte Carlo standard error (MCSE), the standard deviation (SD), the coverage
probability (95%) of the different analysis methods when the event risk is moderate (25%)
Proposed method Naive method
risk, censoring, η∗1, η∗2 Bias MCSE SD CP Bias MCSE SD CP
0.25, 0.00, 0.90, 0.80 0.0135 0.1083 0.1287 0.9100 0.0790 0.0805 0.0825 0.8400
0.25, 0.00, 0.85, 0.85 0.0107 0.1056 0.1300 0.9260 0.0784 0.0793 0.0823 0.8420
0.25, 0.00, 0.80, 0.90 0.0191 0.1102 0.1270 0.9020 0.0821 0.0822 0.0823 0.8220
0.25, 0.00, 0.85, 0.75 -0.0233 0.1328 0.1476 0.9320 0.0832 0.0853 0.0824 0.8120
0.25, 0.00, 0.95, 0.85 0.0521 0.0937 0.1115 0.8700 0.0833 0.0800 0.0824 0.8420
0.25, 0.15, 0.90, 0.80 0.0130 0.1099 0.1297 0.9160 0.0755 0.0832 0.0836 0.8480
0.25, 0.15, 0.85, 0.85 0.0276 0.1071 0.1278 0.8980 0.0893 0.0809 0.0836 0.8180
0.25, 0.15, 0.80, 0.90 0.0183 0.1105 0.1296 0.9060 0.0810 0.0837 0.0837 0.8460
0.25, 0.15, 0.85, 0.75 -0.0240 0.1268 0.1503 0.9160 0.0818 0.0827 0.0837 0.8300
0.25, 0.15, 0.95, 0.85 0.0498 0.0922 0.1138 0.8920 0.0808 0.0795 0.0837 0.8720
0.25, 0.30, 0.90, 0.80 0.0308 0.1082 0.1266 0.8960 0.0872 0.0830 0.0833 0.8240
0.25, 0.30, 0.85, 0.85 0.0255 0.1079 0.1282 0.9020 0.0849 0.0807 0.0832 0.8080
0.25, 0.30, 0.80, 0.90 0.0262 0.1042 0.1274 0.9100 0.0844 0.0806 0.0832 0.8300
0.25, 0.30, 0.85, 0.75 -0.0161 0.1284 0.1491 0.9180 0.0846 0.0837 0.0845 0.8260
0.25, 0.30, 0.95, 0.85 0.0583 0.1006 0.1141 0.8500 0.0871 0.0868 0.0866 0.8280
Bias=estimated treatment effect−(−0.28); η∗1 : mean of the prior distribution of η1; η∗2 : mean of the
prior distribution of η2;
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Table 6: Simulation results with uniform prior distribution of parameter comparing the
bias, the Monte Carlo standard error (MCSE), the standard deviation (SD),the coverage
probability (95%) of the different analysis methods when the event risk is high (35%)
Proposed method Naive method
Bias MCSE SD CP Bias MCSE SD CP
risk, censoring, η∗1, η∗2 (mcse) (mcse) (mcse) (mcse) (mcse) (mcse)
0.35, 0.00, 0.90, 0.80 0.0263 0.0903 0.1162 0.9300 0.0823 0.0699 0.0702 0.7860
0.35, 0.00, 0.85, 0.85 0.0251 0.0863 0.1172 0.9420 0.0823 0.0665 0.0701 0.7980
0.35, 0.00, 0.80, 0.90 0.0235 0.0884 0.1163 0.9260 0.0785 0.0689 0.0701 0.7920
0.35, 0.00, 0.85, 0.75 -0.0133 0.0994 0.1356 0.9600 0.0836 0.0658 0.0701 0.8040
0.35, 0.00, 0.95, 0.85 0.0561 0.0788 0.1022 0.8860 0.0808 0.0697 0.0701 0.8020
0.35, 0.15, 0.90, 0.80 0.0330 0.0871 0.1172 0.9120 0.0847 0.0684 0.0719 0.8020
0.35, 0.15, 0.85, 0.85 0.0273 0.0900 0.1190 0.9180 0.0825 0.0697 0.0718 0.8020
0.35, 0.15, 0.80, 0.90 0.0193 0.0900 0.1191 0.9380 0.0732 0.0712 0.0719 0.8300
0.35, 0.15, 0.85, 0.75 -0.0077 0.1070 0.1362 0.9520 0.0851 0.0719 0.0718 0.7540
0.35, 0.15, 0.95, 0.85 0.0646 0.0814 0.1019 0.8740 0.0848 0.0731 0.0718 0.7820
0.35, 0.30, 0.90, 0.80 0.0371 0.0911 0.1197 0.9200 0.0866 0.0720 0.0750 0.7960
0.35, 0.30, 0.85, 0.85 0.0264 0.0959 0.1205 0.9280 0.0786 0.0761 0.0729 0.0802
0.35, 0.30, 0.80, 0.90 0.0257 0.0904 0.1204 0.9320 0.0759 0.0723 0.0729 0.8340
0.35, 0.30, 0.85, 0.75 -0.0026 0.1131 0.1396 0.9300 0.0795 0.0765 0.0730 0.9300
0.35, 0.30, 0.95, 0.85 0.0701 0.0796 0.1040 0.8700 0.0884 0.0729 0.0749 0.7940
Bias=estimated treatment effect−(−0.28); η∗1 : mean of the prior distribution of η1; η∗2 : mean of the
prior distribution of η2;
Table 7: Effect of HAART on the time to developing clinical AIDS or death among HIV-
positive patients
Model Hazard ratio Confidence interval
Model 1 0.613 0.457-0.821
Model 2 0.436 0.228-0.833
Model 3 0.403 0.198-0.819
Model 4 0.402 0.203-0.796
Model 1: standard marginal structural Cox model;
Model 2: the proposed method with η∗1 = 0.84 and η
∗
2 = 0.8 ;
Model 3: the proposed method with η∗1 = 0.79 and η
∗
2 = 0.85 ;
Model 4: the proposed method with η∗1 = 0.74 and η
∗
2 = 0.90 ;
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